Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials

Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials

OverviewCannabinoids have gained increasing attention for their therapeutic potential in treating several neurological conditions, including neurodegenerative diseases, chronic pain, and epilepsy. This review aims to assess the current clinical trials investigating cannabinoids, primarily Tetrahydro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alqassem Y. Hakami, Fahad S. Alshehri
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Pharmacology
Subjects:	neurodegenerative neurological tetrahydrocannabinol cannabidiol clinical trials
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1521792/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Current chromatographic methods to determine cannabinoids in biological samples: A review of the state-of-the art on sample preparation techniques
by: Igor Gustavo Carvalho Oliveira, et al.
Published: (2024-12-01)

Safety of cannabidiol products as a social issue: A case series
by: Yukari Maki, et al.
Published: (2024-01-01)

Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta‐9‐Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple Routes
by: Lixuan Qian, et al.
Published: (2025-01-01)

Compassionate use of medicinal Cannabis for pain treatment in children with Klippel-Trenaunay Syndrome. Case report
by: Michelle dos Santos Severino Costa, et al.
Published: (2024-12-01)

Trends for Clinical Trials on Medicinal Products for Neurological Disorders in Lithuania and Europe
by: Emilijus Žilinskas, et al.
Published: (2024-03-01)

Feasibility pilot of a novel coaching intervention to optimize cannabis use for chronic pain management among Veterans
by: Kevin F. Boehnke, et al.
Published: (2025-01-01)

Neurological history both twinned and queried by generative artificial intelligence
by: Jung-Hyun Lee, et al.
Published: (2025-01-01)

Cannabinoids for treating psychiatric disorders in youth: a systematic review of randomized controlled trials
by: Patrick Köck, et al.
Published: (2024-12-01)

Quantification and time course of subjective psychotropic and somatic effects of tetrahydrocannabinol – a prospective, single-blind, placebo-controlled exploratory trial in healthy volunteers
by: Maren Kleine-Brueggeney, et al.
Published: (2024-12-01)

Psychobiotics, Novel Therapeutic Agents for the Psychiatric Disorders
by: Praveen Reddy P., et al.
Published: (2025-02-01)

Efficiency and safety of cannabinoid medical use: an analysis of discussions and observed trends on Instagram
by: Olena Litvinova, et al.
Published: (2024-12-01)

Macamides as Potential Therapeutic Agents in Neurological Disorders
by: Karin J. Vera-López, et al.
Published: (2024-11-01)

Effects of elastic therapeutic taping on reducing drooling in children with neurological disorders: a systematic review of randomized controlled trials
by: Krystal Tsz Ting Lam, et al.
Published: (2024-12-01)

3D Printed Bigel: A Novel Delivery System for Cannabidiol-Rich Hemp Extract
by: Anna Gościniak, et al.
Published: (2024-11-01)

Novel trial designs: Master protocol trials
by: Priya Ranganathan, et al.
Published: (2025-01-01)

Cannabidiol Supplements in Romania: Bridging the Gap Between Marketed Claims and Clinical Reality
by: Corina Andrei, et al.
Published: (2024-11-01)

Distribution of trial registry numbers within full-text of PubMed Central articles: implications for linking trials to publications and indexing trial publication types
by: Arthur M. Holt, et al.
Published: (2025-01-01)

Chemical analysis and concentrations of cannabidiol substances used for refractory epilepsy in Chilean patients. An underestimated worldwide risk
by: Loreto Ríos‐Pohl, et al.
Published: (2024-12-01)

Neurology : pre test self- assessment and review /
by: Anschel, David
Published: (2006)

Functional Neurological Disorder and Autism Spectrum Disorder: A Complex and Potentially Significant Relationship
by: Belen Gonzalez‐Herrero, et al.
Published: (2024-12-01)

Potential cytotoxic effect of cannabidiol against human glioblastoma cells in vitro
by: Justyna Lasota, et al.
Published: (2024-09-01)

Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential
by: Mi-bo Tang, et al.
Published: (2025-02-01)

Role of cannabidiolic acid or the combination of cannabigerol/cannabidiol in pain modulation and welfare improvement in horses with chronic osteoarthritis
by: Francesca Aragona, et al.
Published: (2024-12-01)

Remote ischaemic conditioning for neurological disorders—a systematic review and narrative synthesis
by: Ali Alhashimi, et al.
Published: (2024-12-01)

Promising Neuroprotective Effects of Dracocephalum Species: Mechanistic Perspectives
by: Marjan Talebi, et al.
Published: (2024-12-01)

Cost of care associated with utilization of telehealth in clinical trials
by: Emily Gleason, et al.
Published: (2024-12-01)

Predicting accrual success for better clinical trial resource allocation
by: Sisi Ma, et al.
Published: (2025-01-01)

Editorial: Respiratory dysfunction in neurological disease and injury: novel mechanisms and potential therapeutics
by: Savannah Lusk, et al.
Published: (2025-01-01)

Innovative interdisciplinary emergency neurology rotation: Building bridges for enhanced patient care
by: S Lahri, et al.
Published: (2024-09-01)

Kinesiotherapy for Post-stroke Rehabilitation： Analysis of Characteristics of Clinical Trials in the Past 20 Years Based on Clinical Trials Registry Platform
by: WANG Hui, et al.
Published: (2022-10-01)

Conducting clinical trials with self-collection of pharmacokinetic samples: Experience from an exploratory, phase 1, open-label trial of centanafadine SR in healthy individuals
by: Chelsea Ye, et al.
Published: (2025-02-01)

Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey
by: Tangui Barré, et al.
Published: (2024-01-01)

Neurological examination is changing
by: A. Jasionis, et al.
Published: (2020-06-01)

Near Peer Learning in Neurology Residency Training on Electromyography
by: TAN Ying, et al.
Published: (2024-08-01)

A maturity model for Clinical Trials Management Ecosystem
by: Shruti Sehgal, et al.
Published: (2025-01-01)

Characteristics of the Functional Independence Measure (FIM) Scale in Terms of Neurological Conditions
by: Karolina Filipska-Blejder, et al.
Published: (2024-09-01)

Evaluating factors influencing mortality, neurological morbidity and length of stay in adults admitted with community-onset brain abscess in a UK tertiary referral centre
by: David Hettle, et al.
Published: (2024-11-01)

Safety assessment of female sexual hygiene product containing cannabidiol in new zealand white rabbit and clinical trial
by: Atiwut Kamudhamas, et al.
Published: (2024-12-01)

Impact of centrifugal therapeutic plasma exchange on platelet counts in patients with neurological autoimmune diseases
by: GAO Qingmei, et al.
Published: (2024-12-01)

Long-Term Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a 3-Year Open-Label Extension Study
by: Caroline J. Stone, et al.
Published: (2025-01-01)